摘要
目的 :总结 5 0例多发性骨髓瘤 (MM)患者的临床治疗经验。方法 :对 5 0例MM患者的临床资料进行回顾性分析。结果 :移植组与未移植组生存率无差异。使用IFNα治疗者生存率高。使用帕米磷酸二钠的患者生活质量明显改善。使用反应停效果不确定。结论 :a)自体外周血造血干细胞移植 (AutoPeripheralBloodStemCellTransplantation ,APB SCT)及IFNα治疗可改善MM患者预后 ,延长其生存期。b)帕米磷酸二钠可改善患者生存质量 ,延长生存期。c)反应停治疗对难治性MM有效。
Objective To summarize the experience in the management of multiple myeloma (MM). Methods Retrospective analysis was made of the data of 50 patients with MM. Results There was no difference between transplantation group and non-transplantation group in the survival rate. The survival rate was higher in the patients receiving IFNα,the life quality was improved in the patients having PMPNα,and thalidcmide for MM was not certain. Conclusion Auto peripheral blood stem cell transplantation (APBSCT) and IFNα may improve the prognosis and prolong the survival time. PMPNα 2 may improve patients' life quality and prolong their survival time. Thalidcmide is effective for refractory MM.
出处
《山西职工医学院学报》
CAS
2002年第4期6-7,共2页
Journal of Shanxi Medical College for Continuing Education
